Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases: a multicohort, multicenter, exploratory trial

Abstract This multicohort phase II trial (ALTER-G-001; NCT05262335) aimed to assess the efficacy of first-line anlotinib plus chemotherapy for gastrointestinal (GI) cancer patients with unresectable liver metastases. Eligible patients with colorectal cancer (Cohort A) or noncolorectal and nonesophag...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Jun-Wei Wu, Chen-Fei Zhou, Zheng-Xiang Han, Huan Zhang, Jun Yan, Jun Chen, Chun-Bin Wang, Zhi-Quan Qin, Yong Mao, Xin-Yu Tang, Liang-Jun Zhu, Xiao-Wei Wei, Dong-Hai Cui, Xiu-Li Yang, Min Shi, Li-Qin Zhao, Jin-Ling Jiang, Wei-You Zhu, Hong-Mei Wang, Chun Wang, Ling-Jun Zhu, Jun Zhang
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Nature Publishing Group 2024-12-01
Цуврал:	Signal Transduction and Targeted Therapy
Онлайн хандалт:	https://doi.org/10.1038/s41392-024-02051-4
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!